Revision history of "Phase We measure escalation along with pharmacokinetic look at a pair of various schedules involving LY2334737 an oral gemcitabine prodrug within patients along with superior strong cancers"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.